GEORGE BURGESS: Open Payments
NPI 1376847210 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,421 in 160 payments from 25 companies in 2025. Trend: 2023 $4,784 · 2024 $2,992 · 2025 $3,421
Food & beverage: $3,410Education: $11
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 15 | $531 |
| GlaxoSmithKline, LLC. | 22 | $376 |
| AstraZeneca Pharmaceuticals LP | 17 | $319 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $222 |
| JAZZ PHARMACEUTICALS INC. | 12 | $214 |
| Regeneron Healthcare Solutions, Inc. | 14 | $202 |
| Insmed, Inc. | 13 | $193 |
| Lilly USA, LLC | 7 | $171 |
| Actelion Pharmaceuticals US, Inc. | 5 | $140 |
| ZOLL Respicardia, Inc. | 1 | $128 |
Products named: INSPIRE, TRELEGY ELLIPTA, DUPIXENT, XYWAV, Arikayce, FASENRA, ZEPBOUND, remede System.
Industry payments across TX — which companies pay providers there.
